Maternal and neonatal risk factors for early-onset group B streptococcal disease: a case control study

被引:16
作者
Al-Kadri, Hanan M. [1 ]
Bamuhair, Samira S. [2 ]
Al Johani, Sameera M. [3 ]
Al-Buriki, Namsha A. [1 ]
Tamim, Hani M. [4 ]
机构
[1] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Dept Obstet & Gynecol, Riyadh, Saudi Arabia
[2] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Dept Bas Med Sci, Riyadh, Saudi Arabia
[3] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Microbiol Div, Riyadh, Saudi Arabia
[4] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Dept Med Educ, Riyadh, Saudi Arabia
关键词
group B streptococcus; neonatal morbidity; maternal morbidity; antenatal screening;
D O I
10.2147/IJWH.S52206
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: To identify the prominent maternal and neonatal risk factors associated with early- onset group B streptococcus ( EOGBS) disease in neonates and to determine their importance by comparing them with a control group. Setting: Neonatal unit at King Abdulaziz Medical City, Riyadh, Kingdom of Saudi Arabia. Patients: Cases were infants <7 days of age with invasive group B streptococcus ( GBS) disease diagnosed between January 1, 2000 and December 31, 2009. Controls were healthy infants born in the same hospital during the same period having the same birth weight and gestational age category. Main outcome measures: Maternal risk factors for developing EOGBS disease, feto-maternal and neonatal clinical data, their morbidities, mortalities, and length of hospital stay. Results: A total of 99 cases and 200 controls were included. The majority of cases presented in the first 72 hours of life (62/99 [63.9%]), of which 87/99 (89.7%) had at least one clinical risk factor for the development of EOGBS disease. Mothers of neonates with EOGBS disease were more likely to have GBS bacteriuria (odds ratio [OR] 10.76, 95% confidence interval [CI] 1.24-93.42), infection in the peripartum period (OR 8.92, CI 2.87-27.68), and temperature >= 38 degrees C (OR 7.10, CI 2.50-20.17). GBS disease was associated with premature rupture of membranes and fetal tachycardia (P<0.01 for both). Neonates with EOGBS disease were more likely to have respiratory distress disease and convulsions, require tube feeding, and have longer hospital stays compared with the controls (P<0.01 for all). Stepwise multiple logistic regression has identified three risk factors that were associated with the highest tendency for the development of EOGBS disease. These were lack of antenatal attendance (OR = 0.30 and CI 0.98-0.88), rupture of membranes (OR = 9.62 and CI 3.1-29.4), and antibiotic use in labor (OR = 0.16 and CI 0.38-0.67). Conclusion: A number of maternal risk factors were significantly associated with EOGBS disease. Taking these factors into consideration may result in preventing the occurrence of EOGBS disease, improve maternal and neonatal medical care, decrease their hospital stay, and reduce unnecessary hospital resource utilization.
引用
收藏
页码:729 / 735
页数:7
相关论文
共 27 条
[1]  
American College of Obstetricians and Gynecologists, 2002, OBSTET GYNECOL, V100, P1405
[2]   Group B streptococcal infections [J].
Baker, CJ .
CLINICS IN PERINATOLOGY, 1997, 24 (01) :59-+
[3]   Neonatal group B streptococcal infection in South Bedfordshire, 1993-1998 [J].
Beardsall, K ;
Thompson, MH ;
Mulla, RJ .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2000, 82 (03) :F205-F207
[4]  
Benitz WE, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e77
[5]  
Boyer K M, 1985, Antibiot Chemother (1971), V35, P267
[6]   EARLY-ONSET NEONATAL GROUP-B STREPTOCOCCAL SEPTICEMIA IN SIBLINGS [J].
CARSTENSEN, H ;
CHRISTENSEN, KK ;
GRENNERT, L ;
PERSSON, K ;
POLBERGER, S .
JOURNAL OF INFECTION, 1988, 17 (03) :201-204
[7]  
CROMWELL D, 2007, PREVENTION EARLY ONS
[8]   High maternal body mass index increases the risk of neonatal early onset group B streptococcal disease [J].
Hakansson, Stellan ;
Kallen, Karin .
ACTA PAEDIATRICA, 2008, 97 (10) :1386-1389
[9]   Universal maternal screening for neonatal group B streptococcal disease [J].
Halliday, E ;
Foote, K ;
Dryden, M ;
Heard, M ;
Down, R ;
Ward, J .
LANCET, 2000, 356 (9239) :1407-1408
[10]  
Health Protection Agency, 2007, PYOG NONP STREPT BAC